Heparin and protamine stimulate the production of nitric oxide

Journal of Cardiovascular Surgery

Volumn 37, Issue 5, 1996, Pages 445-452

  Li, Jm ^a   Hajarizadeh, H ^a   La Rosa, C A ^a   Rohrer, M J ^a   Vander Salm, Th J ^a   Cutler, B S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cardiopulmonary bypass; Endothelial cells; Endothelium derived relaxing factor; Heparin; Nitric oxide; Protamine

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; GLYCERYL TRINITRATE; HEPARIN; ISOSORBIDE DINITRATE; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PROTAMINE; VASODILATOR AGENT;

ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOPULMONARY BYPASS; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLITE; NONHUMAN; ORAL DRUG ADMINISTRATION; SWINE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

ADULT; AGED; AGED, 80 AND OVER; CARDIOPULMONARY BYPASS; CELLS, CULTURED; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PROTAMINES; RETROSPECTIVE STUDIES;

EID: 0029909194     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
2. Furchgott RF, Cherry PD, Zawadzki JV. Endothelial cells as mediators of vasodilation of arteries J Cardiovasc Pharmacol 1984;6(Suppl 2):S336-44
3. Vanhoutte PM, Rubanyi GM, Miller VM, Souston DS. Modulation of vascular smooth muscle contraction by the endothelium. Ann Rev Physiol 1986;48:307-20
4. Ignarro LJ, Buga GM, Wood KS, Byrns RE Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide Proc Natl Acad Sci 1987;84:9265-9.
5. Moncada S, Herman AG, Vanhoutte P. Edothelium-derived relaxin factor is identified as nitric oxide Trends Pharmacol Sci 1987a;8:365-8.
6. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrate: The basis for the proposal that acid-activable component of the inhibitory factor from retractor penis is organicnitrate and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte PM, editor. Mechanism of vasodilation. New York: Raven Press, 1988;401-14.
7. Moncada S Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-42.
8. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992;258:1898-902.
9. Culotta E, Koshland DE Jr. NO news is good news. Science 1992;258:1862-5
10. Palmer RMJ, Moncada S Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
11. Moncada S, Higgs A The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
12. Sternbergh WC III, Makhoul RG, Adclman B. Heparin prevents postischemic endothelial cell dysfunction by a mechanism independent of its anticoagulant activity. J Vasc Surg 1993; 17:318-27
13. Horrow JC. Protamine: A review of its toxicity. Anesth Analg 1985;64:348-61.
14. Pearson PJ, Evora PRB, Ayrancioglu K, Schaff HV. Protamine releases endothelium-derived relaxing factor from systemic arteries. A possible mechanism of hypotension during heparin neutralization Circulation 1992;86:289-94.
15. Li JM, Menconi MJ, Wheeler HB et al. Precoating expanded polytetrafluoroethylene grafts alters production of endothelial cell-derived thrombomodulators. J Vasc Surg 1992;15:1010-7.
16. Li JM, Menconi MJ, Wheeler HB, Rohrer MJ, Anderson FA, Cutlers BS Experimental femoral vein reconstruction with expanded polytetrafluoroethylene grafts seeded with endothelial cells Cardiovasc Surg 1993;1:362-8
17. 15N] nitrate in biological fluids. Anl Biochem 1982;126:131-8.
18. Li JM, Fenton RA, Cutler BS, Dobson JG, Jr. Adenosine enahnces nitric oxide production by vascular endothelial cells. Am J Physiol 1995;269 (Cell Physiol 38):C519-23
19. Archer S. Measurement of nitric oxide in biological models. FASEB J 1993;7:349-60.
20. Iwamoto J, Inaba M, Gorfien SF, Battista PJ Direct measurement of nitric oxide from ovine endothelium cultured in endothelial-SFM Focus 1994;16:31-3
21. Fiscus RR. Molecular mechanisms of endothelium-mediated vasodilation. Semin Thromb Hemost Suppl 1988;14 12-22.
22. Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993;70(1):36-41
23. Ignarro LJ. Nitric oxide-mediated vasorelaxation Thromb Haemost 1993;70:148-51.
24. Furchgott RF. EDRF and vascular smooth muscle. J Vasc Med Biol 1991;3:441-2.
25. Barrett ML, Willis AL, Vane JR. Inhibition of platelet-derived mitogen release by nitric oxide (EDRF). Agents Actions 1989; 27:488-91.
26. Yao SK, Ober JC, Krishnaswami A et al. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries Circulation 1992;86:1302-9
27. Broekman MJ, Eiroa AM, Marcus AJ. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: Blockade of aggregation and secretion by an aspirin-insensitive mechanism. Blood 1991;78 1033-40.
28. Snyder SH, Bredt DS. Biological roles of nitric oxide Sci Am 1992;68-77
29. Feelisch M, Noack EA. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987;139:19-30
30. Ochoa JB, Udekwu AO, Billiar TR et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214:621-6.
31. Yokokawa K, Kohno M, Yasunari K, Murakawa K, Horio T, Takeda T. Stimulation by heparin of cGMP production in cultured endothelial cells from spontaneously hypertensive rats Arterioscl Thromb 1991;11:1573a.
32. Clowes AW, Karnovsky MJ Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977; 265:625-6.
33. Gregorius FK, Rand RW Scanning electron microscopic observations of the common carotid artery of the rat. III. Heparin effect on platelets. Surgery 1976;79:584-9.
34. Shanberge JN, Kambayashi J, Nakagawa M. The interaction of platelet with a tritium-labeled heparin Thromb Res 1976;9:595-609.
35. Rohrer MJ, Kestin AS, Ellis PA et al. High-dose heparin suppresses platelet alpha granule secretion. J Vasc Surg 1992; 15:1000-9.
36. Folkman J, Weisz PB, Joullie MM, Li WW, Ewing WR. Control of angiogenesis with synthetic heparin substitutes Science 1989;243:1490-3.
37. Lider O, Baharav E, Mekori YA et al Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparin. J Clin Invest 1989;83:752-6.
38. Carr J The anti-inflammatory action of heparin: heparin as an antagonist to histamine, bradykinin, and prostaglandin E1. Thromb Res 1979;16:507-16
39. Oyanagui Y, Sato S. Heparin, a potent releasing agent of extracellular superoxide dismutase (EC-SOD), suppresses ischemic paw oedema in mice. Free Radic Res Commun 1990; 9:87-99.
40. Hobson RW II, Wright JG, Fox D, Kerr JC. Heparinization reduces endothelial permeability and hydrogen ion accumulation in a canine skeletal muscle ischemia-reperfusion model. J Vasc Surg 1988;7 585-90.
41. Hiebert LM, Liu JM. Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabolites. Atherosclerosis 1990;83:47-51
42. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion involved in the breakdown of endothelium-derived vascular relaxing factor Nature 1986;320:454-6
43. Jaques LB, Hiebert LM. The close relationship of heparin and the vessel wall. Artery 1989;16:140-50
44. Shapira N, Schaff HV, Piehler JM, White RD, Sill JC, Pluth JR. Cardiovascular effects of protamine sulfate in man J Thorac Cardiovasc Surg 1982;84:505-14.
45. Kirklin JK, Chenoweth DE, Naftel DC et al. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and hemodynamic state Ann Thorac Surg 1986;41:193-9.
46. Katz NM, Kim YD, Siegelman R, Ved SA, Ahmed SW, Wallace RB Hemodynamics of protamine administration. J Thorac Cardiovasc Surg 1987;94:881-6.
47. Ando T, Yamasaki M, Suzuki K Protamines: Isolation, characterization, structure, and function. In: Kleinzeller A, Springer GF, Wittmann HG, editors Molecular Biology, Biochemistry and Biophysics Vol 12 New York Springer-Verlag, 1973;12 1-30